% Deal Of The Week %

23andMe

Everything You Need To Know About 23andMe In One Place

23andMe Review

23andMe Review

UPDATED Nov. 2019

23andMe is an impressive DNA testing provider featuring a staggering user count, paired with cutting-edge tools for chromosome browsing, biogeographical ancestry analysis, and health-related results. Read all about this exceptional service in our detailed 23andMe review.

Black Friday dna tests

23andMe Black Friday 2019

October 14, 2019

23andMe Black Friday deals for 2019 present you with the perfect opportunity to grab the DNA testing provider’s at-home ancestry and health-related kits and explore your genetic heritage across 1,500+ regions, potential carrier status for more than 40 conditions, inherited genetic traits, and much more.

23andMe Implements Family Trees

23andMe Implements Family Trees & Expands Regions

October 14, 2019

23andMe, the most popular at-home DNA testing provider, recently announced the implementation of auto-populating family trees paired with a significant expansion of its Western Asian, South Asian, and North African regions. Read this comprehensive report to find out more about these changes and learn what they mean for 23andMe users.

dna Privacy Coalition

23andMe, Ancestry, And Helix Introduce New Privacy Coalition

July 17, 2019

23andMe, Ancestry, and Helix have formed a Privacy Coalition and released a whitepaper outlining the best practices for managing sensitive genetic data obtained from their customers. Congress is also drafting a bill that would legislate the issue on a federal level. Read more in this comprehensive report.

Human Parkinson’s Research

Michael J. Fox Foundation And 23andMe Team Up On A New Platform

May 29, 2019

23andMe has joined forces with The Michael J. Fox Foundation in efforts to provide further insight into Parkinson’s disease through a new tool called Fox DEN (Fox Insight Data Exploration Network) designed to use customer-reported data in 23andMe’s database and combine it with genetic information. Read more in this article.

Genetic Prerequisites For Osteoporosis

23andMe Confirms Genetic Prerequisites For Osteoporosis

February 7, 2019

23andMe’s genetic database provided the necessary samples for the latest study related to genetic prerequisites for low bone density and the development of osteoporosis. The main goal of the study was to find the causal connection between the genetic variations and the illness and help develop potential treatments and identify patients earlier.

23andMe Colorectal Cancer Test

23andMe Gets The Green Light For Its Colorectal Cancer Test

January 29, 2019

After clearing its test for three variants in BRCA1 and BRCA2 genes related to breast cancer, the FDA has also greenlit 23andMe’s test for two variants that influence MUTYH-associated polyposis. This is a rare condition that generally increases the risk of developing colorectal cancer. Learn more about this test in our report.

FDA Approves 23andMe dna

FDA Approves 23andMe’s DTC Genetic Test For Medication Metabolism

November 6, 2018

23andMe’s Personal Genome Service Pharmacogenetic Reports test just got approved by the FDA. The first direct-to-customer screening option of its kind to secure FDA approval, the test is designed to detect potential genetic variants in charge of one’s ability to metabolize certain medications. Learn more about this big win for 23andMe in this article.

23andMe No Longer Lets App Devs

23andMe No Longer Lets App Devs Read Your DNA Data

August 28, 2018

23andMe is severely limiting access to its rich database by disabling its API (application programming interface). This move will have great repercussions on dozens of app developers currently using the data to work on their software. Read all about this decision and find out what the company’s representatives had to say about it.

Join our mailing list to receive exclusive updates, giveaways and coupon codes directly to your inbox.